BRIEF published on 05/14/2024 at 22:40, 2 years 5 months ago Les cinq premiers réseaux remettent en question les réductions budgétaires proposées par l'État de Californie Coupes Budgétaires En Californie Services À L'enfance Premier Réseau 5 Éligibilité Médicale L'éducation De La Petite Enfance
BRIEF published on 05/14/2024 at 22:26, 2 years 5 months ago Bausch Health Announces Updates on Norwich XIFAXAN Litigation and New FDA Submission XIFAXAN Bausch Health Patent Litigation FDA Submission Norwich Pharmaceuticals
BRIEF published on 05/14/2024 at 22:26, 2 years 5 months ago Bausch Health annonce des mises à jour sur le litige Norwich XIFAXAN et une nouvelle soumission à la FDA XIFAXAN Bausch Santé Contentieux Des Brevets Norwich Pharmaceutique Soumission À La FDA
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago Sonnet BioTherapeutics Announces Fiscal Year 2024 Q2 Results and Business Updates Financial Results Clinical Trials Oncology Biopharmaceuticals Sonnet BioTherapeutics
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago Sonnet BioTherapeutics annonce ses résultats du deuxième trimestre de l'exercice 2024 et des mises à jour sur ses activités Résultats Financiers Essais Cliniques Oncologie Sonnet BioTherapeutics Produits Biopharmaceutiques
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago NANOBIOTIX Lance une Étude de Phase 2 sur le Traitement du Cancer du Poumon avec FDA Approval FDA Étude De Phase 2 NANOBIOTIX Cancer Du Poumon NBTXR3
BRIEF published on 05/14/2024 at 22:20, 2 years 5 months ago NANOBIOTIX Launches Phase 2 Lung Cancer Treatment Study with FDA Approval FDA Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer
BRIEF published on 05/14/2024 at 22:15, 2 years 5 months ago GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025 Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF published on 05/14/2024 at 22:15, 2 years 5 months ago GENFIT annonce ses résultats financiers du premier trimestre 2024 et dispose d'une trésorerie disponible jusqu'à fin 2025 Industrie Biopharmaceutique Essais Cliniques Baisse Des Revenus Résultats Financiers De GENFIT Situation De Trésorerie
BRIEF published on 05/14/2024 at 22:10, 2 years 5 months ago Protagonist Therapeutics to Present New Rusfertide Study Data at EHA Congress 2024 Clinical Study Protagonist Therapeutics Rusfertide Polycythemia Vera EHA Congress 2024
Published on 10/21/2026 at 02:45, 3 hours 32 minutes ago Revolve Reports FY2026 Financial Results and Advances Growth Through Project-Level Financing and Strategic Acquisitions
Published on 10/20/2026 at 23:10, 7 hours 7 minutes ago Polaris Renewable Energy Awards Key Supply Contract and Issues Notice to Proceed on Punta Lima Battery Storage Investment
Published on 10/20/2026 at 22:00, 8 hours 17 minutes ago Eagle Plains Increases Saskatchewan Royalty Portfolio
Published on 10/20/2026 at 20:10, 10 hours 7 minutes ago Torq Resources Completes Extension of Credit Facility
Published on 10/20/2026 at 17:00, 13 hours 17 minutes ago GameSquare Announces The "Grand Theft Auto" Effect
Published on 10/20/2026 at 23:39, 6 hours 37 minutes ago EQS-Adhoc: NEXTDC Limited: M3 Melbourne Power Delay and Revised FY27 Guidance
Published on 10/20/2026 at 20:22, 9 hours 55 minutes ago Mise à jour de TerraMaster TerraSync : nouveau partage de fichiers et synchronisation à la demande sur Mac
Published on 10/20/2026 at 19:32, 10 hours 44 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 10 hours 45 minutes ago Aroundtown significantly increases its share in German Residential Real Estate through GCP’s financial investment in LEG Immobilien SE
Published on 10/20/2026 at 19:31, 10 hours 46 minutes ago Grand City Properties S.A. acquires 20% stake in LEG Immobilien SE to drive strong FFO growth
Published on 10/20/2026 at 19:47, 10 hours 29 minutes ago Compagnie Chargeurs Invest becomes Belgrano and reaches a new milestone in the implementation of its public share buyback offer (OPRA)
Published on 10/20/2026 at 19:47, 10 hours 29 minutes ago Compagnie Chargeurs Invest devient Belgrano et franchit une nouvelle étape dans la mise en oeuvre de son OPRA
